Status: Recruiting
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）
This is a multicenter, double-blind, double-dummy, randomized clinical trial comparing the efficacy and safety of tirofiban versus placebo in preventing recurrence of stroke for patients with intracranial artery stenosis and high-risk acute non-disabling cerebrovascular events.
Participants needed: 4,674
Trial details
Phase: Phase 3Age: 40+Biological sex: AllType: InterventionalSponsor: Beijing Tiantan HospitalUpdated: Jul 12, 2024Locations: 5
Eligibility criteria
40 years or older than 40 years; [+5]
Malformation, tumor, abscess or other major non-ischemic brain disease (e.g., mu... [+30]